Lobbying client

PHAROS INNOVATIONS

Health care technology/disease management company.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
16
Filed by
3
Reported in-house
—
Reported by firms
$80,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2008 to 2011

Filings

16 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination (No Activity)
2nd Quarter 2011
DLA PIPER LLP (US) — reported
1st Quarter - Report (No Activity)
1st Quarter 2011
DLA PIPER LLP (US) — reported
4th Quarter - Report (No Activity)
4th Quarter 2010
DLA PIPER LLP (US) — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2010
DLA PIPER LLP (US) — reported
Registration
3rd Quarter 2010
DLA PIPER LLP (US) — reported
2nd Quarter - Termination
2nd Quarter 2010
ALSTON & BIRD LLP $10,000 reported
1st Quarter - Report
1st Quarter 2010
ALSTON & BIRD LLP $20,000 reported
4th Quarter - Report
4th Quarter 2009
ALSTON & BIRD LLP $20,000 reported
3rd Quarter - Report
3rd Quarter 2009
ALSTON & BIRD LLP $20,000 reported
2nd Quarter - Report
2nd Quarter 2009
ALSTON & BIRD LLP $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ALSTON & BIRD LLP 5 $80,000
DLA PIPER LLP (US) 4 —
THE CAPITOL ALLIANCE 4 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 8
Medicare/Medicaid MMM 6

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.